Last updated: 2 July 2024 at 8:24pm EST

Christina Topsoe Net Worth




The estimated Net Worth of Christina Teng Topsoe is at least 258 千$ dollars as of 30 June 2023. Ms. Topsoe owns over 3,000 units of IGM Biosciences stock worth over 115,052$ and over the last 5 years she sold IGMS stock worth over 0$. In addition, she makes 142,961$ as Independent Director at IGM Biosciences.

Ms. Topsoe IGMS stock SEC Form 4 insiders trading

Christina has made over 5 trades of the IGM Biosciences stock since 2019, according to the Form 4 filled with the SEC. Most recently she bought 3,000 units of IGMS stock worth 27,960$ on 30 June 2023.

The largest trade she's ever made was buying 1,284,375 units of IGM Biosciences stock on 18 September 2019 worth over 20,550,000$. On average, Christina trades about 92,747 units every 48 days since 2019. As of 30 June 2023 she still owns at least 9,800 units of IGM Biosciences stock.

You can see the complete history of Ms. Topsoe stock trades at the bottom of the page.





Christina Topsoe biography

Christina Teng Topsoe serves as Independent Director of the Company. Ms. Topsøe has served on the board of directors of Haldor Topsøe A/S, and has served on the board of directors of HTH, its holding company, since June 2015. Ms. Topsøe previously was a lawyer at Allen & Overy LLP and Simpson Thacher and Bartlett LLP. Ms. Topsøe pursued a B.A. in Chinese Studies from the University of Copenhagen, studied Chinese Language and Literature at Peking University, and received an LL.B. from the University of London and an M.B.A. from London Business School and Columbia Business School.

What is the salary of Christina Topsoe?

As the Independent Director of IGM Biosciences, the total compensation of Christina Topsoe at IGM Biosciences is 142,961$. There are 12 executives at IGM Biosciences getting paid more, with Fred M. Schwarzer J.D. having the highest compensation of 926,901$.



How old is Christina Topsoe?

Christina Topsoe is 39, she's been the Independent Director of IGM Biosciences since 2018. There are 20 older and no younger executives at IGM Biosciences. The oldest executive at IGM Biosciences, Inc. is Michael Loberg, 72, who is the Independent Chairman of the Board.

What's Christina Topsoe's mailing address?

Christina's mailing address filed with the SEC is C/O IGM BIOSCIENCES, INC., 325 E. MIDDLEFIELD ROAD, MOUNTAIN VIEW, CA, 94043.

Insiders trading at IGM Biosciences

Over the last 5 years, insiders at IGM Biosciences have traded over 2,263,330$ worth of IGM Biosciences stock and bought 10,358,723 units worth 195,788,133$ . The most active insiders traders include Bros. Advisors Lp667, L.P.B...Group, Llc Green Jeremy Red...Bros. Advisors Lp667, L.P.B.... On average, IGM Biosciences executives and independent directors trade stock every 13 days with the average trade being worth of 942,182$. The most recent stock trade was executed by Julie Hambleton on 25 July 2024, trading 15,132 units of IGMS stock currently worth 21,033$.



What does IGM Biosciences do?

IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non-Hodgkin's lymphoma (NHL). It is also developing IGM-8444, an IgM antibody, which is in Phase 1 clinical trials for the treatment of patients with solid cancers; and IGM-7354, an anti-PD-L1 IgM antibody for the treatment of patients with solid and hematologic malignancies; IGM-2644, a bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins for the treatment of patients with multiple myeloma; and IGM-2537, a bispecific T cell engaging IgM antibody targeting CD123 and CD3 proteins for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and acute lymphoblastic leukemia. It has a collaboration and license agreement with Genzyme Corporation to generate, develop, manufacture, and commercialize IgM antibodies. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California.



What does IGM Biosciences's logo look like?

IGM Biosciences, Inc. logo

Complete history of Ms. Topsoe stock trades at IGM Biosciences

日付
#
会社
インサイダー
取引
取引
株式 1株当たりの株価 合計金額 その後の株式数 ソース
30 Jun 2023 Christina Teng Topsoe
購入する 3,000 9.32$ 27,960$
30 Jun 2023
9,800
12 May 2022 Christina Teng Topsoe
購入する 6,800 14.68$ 99,824$
12 May 2022
6,800
11 Dec 2020 Christina Teng Topsoe
購入する 111,111 90.00$ 9,999,990$
11 Dec 2020
10,400,564
18 Sep 2019 Christina Teng Topsoe
購入する 1,284,375 16.00$ 20,550,000$
18 Sep 2019
1,250,000
18 Sep 2019 Christina Teng Topsoe
購入する 1,284,375 16.00$ 20,550,000$
18 Sep 2019
1,250,000


IGM Biosciences executives and stock owners

IGM Biosciences executives and other stock owners filed with the SEC include: